Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 7SL, cytoplasmic 504, pseudogene (RN7SL504P) is a **pseudogene** of the 7SL RNA gene, meaning it is a non-functional, non-protein-coding, and typically non-expressed sequence in the human genome derived from the RNA component of the signal recognition particle (SRP). Unlike the canonical 7SL RNA gene, which plays crucial roles in SRP-mediated protein targeting to the endoplasmic reticulum, pseudogenes such as RN7SL504P are generally not functional and do not contribute directly to cellular pathways or disease mechanisms. Most 7SL pseudogenes result from reverse transcription and integration events, are truncated or mutated, and are not regarded as therapeutic targets or functional biological entities[1][5][6]. **RN7SL504P** is one of many 7SL pseudogenes widely dispersed in the human genome that are generally not transcribed or functional[1][5][6]. There is no evidence associating this specific pseudogene with disease, biomarker roles, or drug interactions. The functional 7SL RNA gene (not the pseudogene) is a component of the signal recognition particle, which plays an essential role in protein targeting, but *pseudogenes* of this family do not carry out those functions[3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 504, pseudogene (RN7SL504P).